Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem.
Lalueza A, Lora-Tamayo J, Maestro-de la Calle G, Folgueira D, Arrieta E, de Miguel-Campo B, Díaz-Simón R, Lora D, de la Calle C, Mancheño-Losa M, Marchán-López Á, García-Reyne A, Fernández-Ruiz M, Sayas-Catalán J, Serrano A, Cueto-Felgueroso C, San Juan R, García-García R, Catalán M, Villena V, Aguado JM, Lumbreras C; COVID+12 group. Lalueza A, et al. Among authors: cueto felgueroso c. Intern Emerg Med. 2022 Mar;17(2):515-524. doi: 10.1007/s11739-021-02748-2. Epub 2021 Apr 29. Intern Emerg Med. 2022. PMID: 33914228 Free PMC article.
Plasma LDH: A specific biomarker for lung affectation in COVID-19?
Serrano-Lorenzo P, Coya ON, López-Jimenez A, Blázquez A, Delmiro A, Lucia A, Arenas J, Martín MA; COVID-19 ’12 Octubre’ Hospital Clinical Biochemistry Study Group. Serrano-Lorenzo P, et al. Pract Lab Med. 2021 May;25:e00226. doi: 10.1016/j.plabm.2021.e00226. Epub 2021 Apr 21. Pract Lab Med. 2021. PMID: 33898686 Free PMC article.
Can routine laboratory variables predict survival in COVID-19? An artificial neural network-based approach.
Santos-Lozano A, Calvo-Boyero F, López-Jiménez A, Cueto-Felgueroso C, Castillo-García A, Valenzuela PL, Arenas J, Lucia A, Martín MA; COVID-19 Hospital ’12 Octubre’ Clinical Biochemisty Study Group. Santos-Lozano A, et al. Among authors: cueto felgueroso c. Clin Chem Lab Med. 2020 Oct 2;58(12):e299-e302. doi: 10.1515/cclm-2020-0730. Clin Chem Lab Med. 2020. PMID: 33001844 Free article. No abstract available.
Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.
Pascual T, Apellániz-Ruiz M, Pernaut C, Cueto-Felgueroso C, Villalba P, Álvarez C, Manso L, Inglada-Pérez L, Robledo M, Rodríguez-Antona C, Ciruelos E. Pascual T, et al. Among authors: cueto felgueroso c. PLoS One. 2017 Jul 20;12(7):e0180192. doi: 10.1371/journal.pone.0180192. eCollection 2017. PLoS One. 2017. PMID: 28727815 Free PMC article.
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
Lopez-Anglada L, Cueto-Felgueroso C, Rosiñol L, Oriol A, Teruel AI, Lopez de la Guia A, Bengoechea E, Palomera L, de Arriba F, Hernandez JM, Granell M, Peñalver FJ, Garcia-Sanz R, Besalduch J, Gonzalez Y, Martinez RB, Hernandez MT, Gutierrez NC, Puerta P, Valeri A, Paiva B, Blade J, Mateos MV, San Miguel J, Lahuerta JJ, Martinez-Lopez J; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group. Lopez-Anglada L, et al. Among authors: cueto felgueroso c. PLoS One. 2018 Sep 7;13(9):e0203392. doi: 10.1371/journal.pone.0203392. eCollection 2018. PLoS One. 2018. PMID: 30192814 Free PMC article.
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Martínez-López J, Paiva B, López-Anglada L, Mateos MV, Cedena T, Vidríales MB, Sáez-Gómez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordón L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Bladé J, San Miguel JF, Lahuerta JJ; Spanish Multiple Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Group. Martínez-López J, et al. Among authors: cueto felgueroso c. Blood. 2015 Aug 13;126(7):858-62. doi: 10.1182/blood-2015-04-638742. Epub 2015 Jun 18. Blood. 2015. PMID: 26089396 Free PMC article. Clinical Trial.